CYTOSPHERE TECHNOLOGIES PRIVATE LIMITED

In their own words

Our startup aims to strengthen the healthcare diagnostics ecosystem by developing innovative, technology-driven solutions that enhance accuracy, accessibility, and efficiency in clinical testing. We focus on creating advanced diagnostic products and automated systems that address critical gaps in pathology and infectious disease detection. Our core innovations include AI-based software for interpretation and annotation of digitized pathology images, automated slide stainers for tissue diagnostics, and Whole Slide Imaging (WSI) scanners that convert traditional pathology workflows into fully digital processes. These solutions improve turnaround time, reduce manual errors, and enable remote diagnostics, contributing to more consistent and high-quality healthcare delivery. In addition, we develop molecular diagnostic products such as Real-Time PCR kits for diseases including Covid-19, HIV, and tuberculosis, along with specialized antibodies and reagents that support routine and cancer diagnostics. Our products are designed to make advanced diagnostics more affordable while maintaining international quality standards. We operate on a scalable model that integrates local manufacturing with expansion into tier I, II, and III cities and international markets such as Africa and South America. Continuous research and development allow us to upgrade existing diagnostic processes, introduce new technologies, and address evolving healthcare challenges. Through innovation-led development, process improvement, and a strong focus on precision diagnostics, our startup aims to provide cost-efficient, reliable, and accessible diagnostic solutions that can be adopted widely across India and global markets.

Written by the company on its public Startup India profile. Not verified by us.